Bimekizumab Safety in Patients With Psoriasis Achieving Complete Skin Clearance: 4-Year Analysis from 5 Phase 3 3b Trials. J of Skin 2026, 10 (2), s757. https://doi.org/10.25251/v6wwxw80.